Niaid preclinical development support - immunoaffinity purification of HIV-1 ENV proteins
Ended Awarded Last action
- Contract number
- HHSN27200036
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,709,463
Award facts
- Contract value 100% obligated
- $4,709,463.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$184,533 | |
| Definitize Change Order | -$178,700 | |
| Other Administrative Action | $0 | |
| Original award | $5,072,696 |
About this award
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS). The contract, valued at $4,709,463.34, is for NIAID's Preclinical Development Support program focused on the immunoaffinity purification of HIV-1 envelope proteins. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type. This award does not have a set-aside designation. ABL, a for-profit manufacturer of goods, has been awarded numerous federal contracts and grants, particularly from NIH and HHS, to advance the development of medical countermeasures for infectious diseases. The company provides a range of preclinical and clinical development services, including cGMP manufacturing, process development, and analytical testing for vaccines and biologics. This contract is part of NIAID's broader efforts to support the preclinical development of HIV prevention and treatment products.
Quick answers
Who was awarded contract HHSN27200036?
HHSN27200036 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2016.
How much is contract HHSN27200036 worth?
The government has obligated $4,709,463 on HHSN27200036.
Is contract HHSN27200036 an order under another contract?
Yes. HHSN27200036 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200036 competed?
The extent of competition for HHSN27200036 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award